Alexander Storch
Alexander Storch
Verified email at - Homepage
Cited by
Cited by
Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells
A Hermann, R Gastl, S Liebau, MO Popa, J Fiedler, BO Boehm, M Maisel, ...
Journal of cell science 117 (19), 4411-4422, 2004
Direct reprogramming of fibroblasts into neural stem cells by defined factors
DW Han, N Tapia, A Hermann, K Hemmer, S Höing, MJ Araúzo-Bravo, ...
Cell stem cell 10 (4), 465-472, 2012
Treadmill training for patients with Parkinson's disease
J Mehrholz, J Kugler, A Storch, M Pohl, B Elsner, K Hirsch
Cochrane database of systematic reviews, 2015
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double‐blind, randomized, placebo‐controlled study (RECOVER)
C Trenkwalder, B Kies, M Rudzinska, J Fine, J Nikl, K Honczarenko, ...
Movement Disorders 26 (1), 90-99, 2011
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells
A Storch, G Paul, M Csete, BO Boehm, PM Carvey, A Kupsch, J Schwarz
Experimental neurology 170 (2), 317-325, 2001
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak
YG Weber, A Storch, TV Wuttke, K Brockmann, J Kempfle, S Maljevic, ...
The Journal of clinical investigation 118 (6), 2157-2168, 2008
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications
A Storch, CB Schneider, M Wolz, Y Stürwald, A Nebe, P Odin, A Mahler, ...
Neurology 80 (9), 800-809, 2013
Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype
R Krüger, AM Menezes Vieira‐Saecker, W Kuhn, D Berg, T Müller, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
A star-PEG–heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases
U Freudenberg, A Hermann, PB Welzel, K Stirl, SC Schwarz, M Grimmer, ...
Biomaterials 30 (28), 5049-5060, 2009
Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of OriginFrom Neural Stem Cells to Cancer Stem Cells
C Lottaz, D Beier, K Meyer, P Kumar, A Hermann, J Schwarz, M Junker, ...
Cancer research 70 (5), 2030-2040, 2010
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease
A Storch, WH Jost, P Vieregge, J Spiegel, W Greulich, J Durner, T Müller, ...
Archives of neurology 64 (7), 938-944, 2007
Observing Huntington's disease: the European Huntington's disease network's REGISTRY
M Orth, European Huntington's Disease Network
Journal of Neurology, Neurosurgery & Psychiatry 82 (12), 1409-1412, 2011
A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease
PM Carvey, ZD Ling, CE Sortwell, MR Pitzer, SO McGuire, A Storch, ...
Experimental neurology 171 (1), 98-108, 2001
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
Euro I nf: AM ulticenter C omparative O bservational S tudy of A pomorphine and L evodopa I nfusion in P arkinson's D isease
P Martinez‐Martin, P Reddy, R Katzenschlager, A Antonini, A Todorova, ...
Movement Disorders 30 (4), 510-516, 2015
FTDP‐17: an early‐onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
AD Sperfeld, MB Collatz, H Baier, M Palmbach, A Storch, J Schwarz, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
Adherence to antiparkinson medication in a multicenter European study
D Grosset, A Antonini, M Canesi, G Pezzoli, A Lees, K Shaw, E Cubo, ...
Movement disorders: official journal of the Movement Disorder Society 24 (6 …, 2009
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation
M Naumann, A Pal, A Goswami, X Lojewski, J Japtok, A Vehlow, ...
Nature communications 9 (1), 1-17, 2018
Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration
A Storch, AC Ludolph, J Schwarz
Journal of neural transmission 111 (10), 1267-1286, 2004
The system can't perform the operation now. Try again later.
Articles 1–20